Showing 1871-1880 of 2050 results for "".
- Will Fat-freezing Ice Slurries Be the Next Big Thing in Body Contouring?https://modernaesthetics.com/news/will-fat-freezing-ice-slurries-be-the-next-big-thing-in-body-contouring/2472865/An injectable ice “slurry” may selectively reduce unwanted fat, according to research in pigs published in Plastic & Reconst
- Revian: USPTO Grants Patent for Biostimulatory Approachhttps://modernaesthetics.com/news/regina-uspto-grants-patent-for-biostimulatory-approach/2472862/The United States Patent and Trademark Office (USPTO) has awarded to Revian Inc. U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the use
- Ortho Dermatologics Adds Key Staff to Solta Medical Business Unithttps://modernaesthetics.com/news/ortho-dermatologics-adds-key-staff-to-solta-medical-business-unit/2472854/Ortho Dermatologics is staffing up its Solta Medical Business unit. The new appointments include the following: Liz Newman, General Manager, Solta, North America Newman first joined Solta
- Alastin Skincare Receives Third Patenthttps://modernaesthetics.com/news/elastin-skincare-receives-third-patent/2472853/Alastin Skincare, Inc. has received a third US Patent from the United States Patent and Trademark Office. The patent covers Alastin’s innovative science and products. US Patent No. 10,493,011 is entitled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Bod
- Revance's DAXI Now One Step Closer to FDA Nodhttps://modernaesthetics.com/news/revances-daxi-now-one-step-closer-to-fda-nod/2472849/Revance Therapeutics, Inc. has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar lines. Under
- Save the Date: November 20, 2019 Marks National Botox Dayhttps://modernaesthetics.com/news/save-the-date-november-20th-2019-marks-national-botox-day/2472845/November 20, 2019 will be the first-ever National Botox Cosmetic Day. Why Nov. 20? It is the busiest day on record for booking Botox cosmetic treatments in the US. And to commemorate it, Allergan is offering an exclusive deal for one day only where patients can “buy one, get
- Cynosure Rolls Out StimSure for Muscle Toning in Europe, Middle Easthttps://modernaesthetics.com/news/cynosure-rolls-out-stimsure-for-muscle-toning-in-europe-middle-east/2472839/Cynosure, a division of Hologic, is launching StimSure, a non-invasive electromagnetic technology to build and tone muscle in the abdomen, buttocks and thighs, in Europe and the Middle East. CE marked for muscular atrophy, StimSure can be used to strengthen and tighten the abdomina
- Galderma Set to Start Seven New Clinical Studieshttps://modernaesthetics.com/news/galderma-set-to-start-begin-seven-new-clinical-studies/2472838/Galderma is initiating seven clinical studies that seek to support potential, new aesthetic indications including a tear trough indication for Restylane, a facial wrinkles indication for Sculptra Aesthetic as well as several studies supporting an investigational liquid neurotoxin and a Phase 2 st
- FDA Proposes Boxed Warning on Breast Implant Riskshttps://modernaesthetics.com/news/fda-proposes-boxed-warning-on-breast-implant-risks/2472837/The FDA released a statement on its continued efforts to protect women’s health and enhance safety information available to patients considering breast implants. In draft guidance issued on Oct. 24, the FDA proposed labeling
- Merz: Cellfina for Cellulite Cleared for 5 Years of Benefithttps://modernaesthetics.com/news/merz-cellfina-for-cellulite-cleared-for-5-years-of-benefit/2472836/The FDA has cleared a new indication statement for Cellfina that shows the benefits of treatment last for five years, an increase from the previous three-year indication. Cellfina from Merz demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult femal